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A series of 9-P-D-xylofuranosyladenine (xyloA or xyloadenosine) substituted analogs of 2-.5A core trimer 
and tetramer were examined for their ability to be degraded by the 2’,5’-phosphodiesterase activity of cyto- 
plasmic extracts of mouse L cells. Two distinct groups of xyloA-substituted analogs could be readily dis- 
criminated. The first group contained xyloadenosine at the 2’-termini and included A2’pSA2’p5’(xyloA) 
and A~pSA~pSA~pS(xyloA). These oligomers behaved as did their parent oligoadenylates in that they 
were equally sensitive to degradation by the 2’,5‘-phosphodiesterase activity. The second group of 
oligonucleotides bore a xyloadenosine residue in the penultimate nucleotide residues of the oligomers and 
included A2’p5’(xyloA)2’pS(xyloA), (xyloA)2’pS(xyloA)2’p5’(xyloA), A2’p5’A2’p5’(xyloA)2’pS’(xyloA) 
and (xyloA)z’pS’ (xyloA)2’pS(xyloA)2’p5’(xyloA). This group was quite resistant o 2’,5’-phosphodiester- 
ase activity. In all, the findings demonstrate that the r&o ~nfig~ation 3’-hydroxyl group in the ~nultimate 
nucleotide of the oligonucleotide substrate is a prerequisite for the 2’,5’-phosphodiesterase activity. 
1. INTRODUCTION 
The unique 2’ ,5 ‘-linked oligonucleotide, 2-SA 
(ppp5 ’ A2 ’ p5 ’ A2 ’ p5 ’ A), is synthesized in vivo 
and in vitro by the interferon-induced enzyme 
2-5A synthetase, it subsequently may activate the 
2-SA-dependent endonuclease, RNase L and it can 
be degraded to ATP and AMP by a 
2’ ,5’-phosphodiesterase (reviewed in [l-3]). Since 
this latter degradation enzyme is important in the 
contro1 of the biological activity of 2-5A and in 
limiting the activity of 2-5A analogs which may 
serve as potential chemotherapeutic agents, an 
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understanding of the o~gonucleotide structural re- 
quirements of and mechanism of action of this 
2 ’ ,5 ’ -phosphodiesterase activity may be con- 
sidered paramount. 
Recently, we reported [4] that degradation by 
the 2’ ,5’-phosphodiesterase activity requires a 
3 ’ -hydroxyl group on the penultimate nucleotide 
unit of the 2 ’ ,5 ’ -oligonucleotide. Specifically we 
demonstrated that the 3 ’ -deoxyadenosine 
substituted 2-5A analog, pS’A2’p5’(3’dA)- 
2’pS’A, possessed the same high degree of re- 
sistance to degradation by the 2’ ,5 ’ -phospho- 
diesterase activity as did p5 ’ (3 ’ dA)2 ’ p5 ’ (3 ’ dA)- 
2’p5’(3’dA) shown [5,6] to be resistant. On the 
other hand, analogs in which the replacement of 
the 3’-hydroxyl by hydrogen was effected in the 
first or third nucleotide residue of pS’A2’p5’- 
A2’p5’A were much less resistant o degradation 
141. Herein, we examine the 2’ ,5’-phosphodi- 
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esterase resistance of a series of 2-5A core trimer 
and tetramer in which one or more of the adeno- 
sine residues have been replaced by 9-&D-xylo- 
furanosyladenine (xyloadenosine, xyloA). 
2. EXPERIMENTAL 
The preparation of L cell extracts and conditions 
for protein synthesis have been described [8]. 
Oligonucleotide degradation was studied under 
protein synthesis conditions except that amino 
acids and mRNA were omitted. The final concen- 
trations of components of the reaction mixture 
were: L cell extract, 20%; KCl, 120 mM; MgCL, 
3 mM; Hepes, pH 7.5, 30 mM; fl-mercapto- 
ethanol, 6 mM; creatine phosphokinase, 27 
units/ml; ATP, 1 mM; GTP, 0.1 mM; CTP, 
0.6 mM; creatine phosphate, 100 mM. Incuba- 
tions of the specific oligonucleotide in the above 
system were performed at 30°C with aliquots 
withdrawn at the indicated times. After the 
samples were heated at 100°C for 5 min and then 
centrifuged at 10000 x g to remove denatured pro- 
tein, they were analyzed by HPLC by injection 
with a standard (Zchloroadenosine). The condi- 
tions for HPLC were as follows. A Waters Bon- 
dapack Cl8 column (3.9 x 300 mm) was employed 
using a Beckman HPLC system with two model 
110A pumps and a 421 controller. Detection 
was with an ISCO model UA-I absor- 
bance/fluorescence monitor. The integration of 
chromatogram areas was determined using an 
Altex model C-RIA integrator. Four different elu- 
tion programs were employed: (i) O-50070 
methanol/water (1: 1) into ammonium phosphate 
(50 mM), pH 7, for 30 min; (ii) O-50% 
methanol/water (1: 1) into ammonium phosphate 
(50 mM), pH 4, for 30 min; (iii) O-30% 
methanol/water (1: 1) into ammonium phosphate 
(50 mM), pH 7, for 20 min then 30-50% 
methanol/water (1: 1) into ammonium phosphate 
(50 mM), pH 7, for 20 min; (iv) O-30% 
methanol/water (1: 1) into ammonium phosphate 
(50 mM), pH 4, over 20 min then 30-50% 
methanol/water (1: 1) into ammonium phosphate 
(50 mM), pH 4, over 20 min. 
The oligonucleotides A2 ’ p5 ’ A2 ’ p5 ’ A and 
A2’p5’A2’pStA2’p5’A were obtained as de- 
scribed [9] and the xyloadenosine analogs used in 
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this study were prepared according to published 
procedures [lo]. 
3. RESULTS AND DISCUSSION 
The degradation of two distinct series of 
oligonucleotides was addressed in this study. The 
first series were trimers based on the trimer 
A2’p5’A2’pS’A or 2-5A ‘core’. In this series, 
beginning at the 2’-terminus each adenosine 
residue was replaced to give A2’pS’A2’p5 ‘- 
(xyloA) , A2 ’ p5 ’ (xyloA)2 ’ p5 ’ (xyloA) and 
(xyloA)2 ’ p5 ’ (xyloA)2 ’ p5 ’ (xyloA) respectively. 
The second series, based on the tetrameric core 
A2’p5’A2’pSrA2’p5’A, entailed a similar sub- 
stitution scheme except that one position isomer 
was unaccessible; specifically, A2 ’ p5 ’ (xyloA)- 
2’pS’(xyloA)2’pS ‘(xyloA). Thus only the de- 
gradation rates of A2’p5 ‘A2’p5’A2’pS ‘(xyloA), 
A2 ’ p5 ’ A2 ’ p5 ’ (xyloA)2 ’ p5 ’ (xyloA) and (xyloA)- 
2 ’ p5 ’ (xyloA)2 ’ p5 ’ (xyloA)2 ’ p5 ’ (xyloA) were in- 
vestigated. Results for the degradation of the 
trimer series are presented in fig.1 and those for 
the degradation of the tetramer series are presented 
in fig.2. Immediately obvious from inspection of 
figs 1 and 2 is that there is a tremendous dichotomy 
in behavior between two distinct groups of 
oligonucleotide trimers or tetramers. The first 
group, those that were rapidly degraded by the 
phosphodiesterase activity, included A2’p5 ‘- 
A2’p5’A, A2’p5’A2’pS’(xyloA), A2’pS’A2’- 
p5’A2’p5’A and A2’p5’A2’pS’A2’pS’(xyloA). 
The half-lives for the oligoadenylate cores were ap- 
proximately 45 min under these particular condi- 
tions. The second group, those that were quite 
resistant o the action of the phosphodiesterase, in- 
cluded A2 ’ p5 ’ (xyloA)2 ’ p5 ’ (xyloA), (xyloA)2 ’ - 
p5’(xyloA)2’p5 ‘(xyloA), A2’p5’A2’p5’(xyloA)- 
2 ’ p5 ’ (xyloA) and (xyloA)2 ’ p5 ’ (xyloA)2 ’ p5 ’ - 
(xyloA)2’pS ‘(xyloA). The half-life of this latter 
group greatly exceeded 2 h. Thus, any analog with 
a xyloA nucleoside unit in the penultimate position 
of the oligonucleotide was resistant o degradation 
by the 2’ ,5 ‘-phosphodiesterase. A simple sub- 
stitution of xyloA at the 2 ’ -terminus was not suffi- 
cient to induce resistance; in fact, such analogs had 
no more stability to degradation than the parent 
2-5A core trimer or tetramer. 
The results obtained herein are in agreement 
with our earlier findings [4] that substitution by 
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Pig. 1. Degradation of various oligoadenylate rimers 
substituted with xyIoA by the 2’ ,5 ~-phosphodiester~e 
activity of mouse L cells. Reaction mixtures were made 
up as described and were incubated at 30°C. At the 
indicated times, aliquots were withdrawn and analyzed 
by HPLC. initial concentrations of the oligomers were 
5 x lo-‘M. 0, A2’p5’A2’pS1A; v, A2’pS’A2’- 
p5 ’ (xyloA); v , A2 ’ p5 ’ (xyloA)2 ’ p5 ’ (xyloA); n , 
(xyloA)2 ’ p5 ’ (xyloA)2’ p5 ’ (xyloA). 
hydrogen of the 3 ’ -hydroxyl group of the 
pen~timate adenosine residue of pS’A2’p5’A2’- 
p5 ‘A led to resistance to 2’ ,5 ’ -phosphodiesterase 
activity. The present results also extend this obser- 
vation to include the generality that the inversion 
of configuration from ribo to xylo of the 3 ‘- 
hydroxyl moiety of the penultimate AMP unit of 
a 2 ’ ,5 ’ -oligoadenylate ffects a dramatic increase 
in 2 ’ ,5 ’ -phosphodiesterase resistance. Of par- 
ticular interest was the observation that the 2-5A 
core analogs terminating in xyloadenosine residues 
were no more resistant to degradation than the 
parent oligoadenylate. This, coupled with the 
observation that the 3 ’ -deoxyadenosine substi- 
tuted analog p5’AZ’p5’A2’p5’(3’dA) was de- 
graded only slightly less quickly than the parent 
triadenylate, makes it improbable that the 
3 ’ -hydroxyl group of the 2’ -terminal residue of 
the 2,5’-linked oligomer is a critical recognition 
point for the 2’,5’-phosphodiesterase. That the 
3’-hydroxyl moiety of the penultimate nucleotide 
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TIME (mmutesI 
Fig.2. Degr~ation of various ol~goadenylate tramers 
substituted with xyloA by the 2’ ,5 ‘-phosphodiesterase 
activity of mouse L cells. For details, consult the 
experimental section and the legend to fig.1. Com- 
pounds studied were as follows: 0, A2’p5’A2’pSiA2’- 
pS’A; A, A2’pS’A2’pS’A2’pS’(xyloA); A, A2’p5’- 
A2 ’ p5 ’ (xyloA)Z ’ p5 ’ (xyloA); l , (xyloA)2 ’ p5 ’ (xyloA)- 
2 ’ p5 ’ (xyloA)2 ’ pS ’ (xyloA). 
serves such a critical role in the action of the 
2’ ,5’-phosphodiesterase may not be considered 
unexpected since it is the peculiar stereochemical 
relationships of the 3 ’ -hydroxyl, the 2 ’ ,5 ’ -phos- 
phodiester linkage and the remainder of the 
molecule that would serve to unambiguously iden- 
tify such an oligonucleotide whereas such recogni- 
tion information would be lacking in the 2-ter- 
minal unit. It remains to be determined whether or 
not this requirement for a [~j~o-3’~hydroxyl con- 
figuration is due to a specific recognition point on 
the 2’,5’-phosphodiesterase for the hydroxyl 
group, the requisite formation of a 2’ ,3 ’ -cyclic 
phosphate intermediate of degradation, or both. 
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